Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 4,460.00
-30.00 (-0.67%)
Aug 12, 2026, 1:04 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 104.43 billion as of August 11, 2026. Its market cap has decreased by -51.93% in one year.
Market Cap
104.43B
Enterprise Value
66.38B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,460.00
ChartMarket Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 104.43B, a decrease of -34.83%. That is a compound annual growth rate of -7.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 104.43B | -55.06% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 156.56B |
| NeoImmuneTech | 151.17B |
| Macrogen | 133.57B |
| Genexine | 120.07B |
| MedPacto | 94.94B |
| iNtRON Biotechnology | 80.78B |
| Prestige BioPharma | 79.33B |
| CG Invites | 76.43B |